HeyJaredAllison Gatlin
- Indexed articles, last 90 days
- 3
- Latest publication
- Sep 30, 2026
- Outlet visibility, for Investor's Business Daily
- Top 100K sites
- Earliest in this view
- Sep 30, 2026
Latest articles
Biotech Pulls The Ultimate Bull Move, As Its Biggest Rival Dives (opens the original)
Read excerpt
A district judge ruled Wednesday that Liquidia (LQDA) infringed on United Therapeutics' (UTHR) patents with its drug, Yutrepia. The stocks diverged on the announcement. Yutrepia treats two forms of high blood pressure in the lungs. It closely rivals United's Tyvaso. The duo have spent years locked in a heated battle over their compounds. On Wednesday, a judge sided with United… Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Move Aside Retatrutide. Lilly Just Beat Its Next-Gen Obesity Drug. (opens the original)
Read excerpt
Eli Lilly (LLY) already beat its next-generation weight-loss drug, retatrutide, and it hasn't even hit the market. The new contender, EloraTZP, helped patients with type 2 diabetes lose an average of 23.3% of their body weight, compared with just 14.8% weight loss in patients taking tirzepatide. That translated to 54.1 pounds and 34.4 pounds, respectively, over the course of 48… Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
This Stock, Up Almost 70%, May Have Found Cancer's Holy 'Grail' (opens the original)
Read excerpt
Grail (GRAL) stock has catapulted in September, reaching a record high, as the Food and Drug Administration mulls its Galleri blood test, a contender in the multibillion-dollar cancer detection market. Earlier in the month, an FDA advisory committee backed Galleri's safety and effectiveness, saying the benefits outweigh the risks. Now, Galleri is on the cusp of a full approval. Though… Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 100K sites
For Investor's Business Daily, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.